Skip to main content

Table 2 a) Prevalence of respiratory tract infections (RTIs) outcomes and b) frequency of long lasting RTIs

From: Obesity and risk of respiratory tract infections: results of an infection-diary based cohort study

a)

 

All (N = 1455):

Male (N = 524):

Female (N = 931):

 

Outcome indicators

Prevalence (%)

95% CI

Prevalence (%)

95% CI

Prevalence (%)

95% CI

P-valuea (gender)

Monthly level:

 AnyRTI

36.3

(34.9;37.7)

35.1

(32.7;37.5)

37.0

(35.2;38.7)

0.223

 AnyURTI

31.5

(30.2;32.9)

29.9

(27.6;32.1)

32.4

(30.7;34.1)

0.077

 AnyLRTI

7.9

(7.1; 8.8)

9.0

(7.3;10.6)

7.4

(6.4; 8.3)

0.097

 Sinusitis

7.0

(6.2; 7.8)

5.3

(4.1; 6.5)

7.9

(6.9; 8.9)

< 0.001

 Rhinitis

26.6

(25.4;27.9)

25.8

(23.7;27.9)

27.0

(25.4;28.6)

0.368

 Otitis media

0.94

(0.67; 1.21)

0.87

(0.49; 1.24)

0.98

(0.61; 1.35)

0.674

 Pharyngitis/Laryngitis

10.5

(9.6;11.3)

9.7

(8.2;11.2)

10.9

(9.8;11.9)

0.218

 Tonsillitis

1.9

(1.6; 2.3)

1.4

(0.8; 2.0)

2.2

(1.8; 2.7)

0.040

 Influenza-like illness

11.4

(10.6;12.1)

11.3

(10.1;12.6)

11.4

(10.4;12.4)

0.942

 Bronchitis

7.8

(7.0; 8.7)

8.9

(7.2;10.5)

7.3

(6.3; 8.2)

0.102

 Pneumonia

0.21

(0.11; 0.30)

0.26

(0.07; 0.45)

0.17

(0.08; 0.27)

0.433

 Pleurisy

0.10

(0.03; 0.17)

0.17

(0.00; 0.34)

0.06

(0.01; 0.11)

0.220

 Other acute resp. Infections

2.4

(2.0; 2.8)

1.9

(1.1; 2.7)

2.6

(2.1; 3.1)

0.137

  ≥ 3 RTIs

8.6

(7.8; 9.4)

8.1

(6.8; 9.4)

8.9

(7.9; 9.8)

0.362

 Long RTIs

13.0

(11.9;14.0)

12.7

(10.8;14.6)

13.1

(11.8;14.4)

0.737

 Upper 10% in diary score

10.0

(9.1;10.9)

10.0

(8.4;11.6)

10.0

(8.9;11.1)

0.992

Seasonal level:

  ≥ 4 months RTIs

19.3

(17.6;21.0)

18.6

(15.9;21.4)

19.6

(17.5;21.8)

0.566

  ≥ 3 long RTIs

9.2

(8.1;10.4)

9.9

(7.8;11.9)

8.9

(7.4;10.3)

0.445

 Upper 10% in diary score

10.2

(8.9;11.5)

10.7

(8.3;13.1)

9.9

(8.3;11.5)

0.602

Individual-level:

 Upper 10% in diary score

10.0

(8.4;11.5)

9.9

(7.4;12.5)

10.0

(8.1;11.9)

0.968

b)

 

All (N = 1455):

Male (N = 524):

Female (N = 931):

 
 

Frequencyb (%)

95% CI

Frequencyb (%)

95% CI

Frequencyb (%)

95% CI

P-valuea (gender)

Outcome indicators

 Any long RTI

35.5

(33.4;37.6)

36.2

(32.4;39.9)

35.2

(32.7;37.7)

0.674

 Sinusitis

41.1

(36.7;45.5)

45.0

(35.4;54.6)

39.6

(34.8;44.5)

0.326

 Rhinitis

26.2

(24.0;28.4)

27.4

(23.4;31.4)

25.5

(22.9;28.1)

0.435

 Otitis media

32.6

(22.7;42.6)

36.7

(18.1;55.4)

31.1

(19.1;43.0)

0.616

 Pharyngitis/Laryngitis

27.8

(24.6;30.9)

32.6

(26.7;38.6)

25.5

(22.0;29.1)

0.043

 Tonsillitis

16.7

(11.7;21.8)

23.7

(12.3;35.2)

14.4

(8.9;20.0)

0.153

 Influenza-like illness

26.0

(23.1;28.8)

28.8

(23.8;33.7)

24.5

(21.1;28.0)

0.175

 Bronchitis

48.2

(44.5;51.9)

48.3

(41.7;54.9)

48.1

(44.0;52.2)

0.965

 Pneumonia

59.0

(42.0;75.9)

66.7

(44.4;88.9)

52.4

(29.4;75.4)

0.382

 Other acute resp. infections

46.5

(39.7;53.3)

55.8

(42.5;69.0)

42.9

(35.5;50.4)

0.097

  1. athe p-value for the gender difference is based on the Fisher’s exact test for comorbidities and on chi2 otherwise
  2. bfor all months in which a respective infection was reported